share_log

Insider Buying: InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Purchases 35,500 Shares of Stock

Insider Buying: InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Purchases 35,500 Shares of Stock

内幕购买:InspirreMD,Inc.(纽约证券交易所代码:NSPR)董事购买35,500股股票
Financial News Live ·  2022/08/22 17:31

InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating) Director Gary S. Roubin acquired 35,500 shares of the company's stock in a transaction dated Thursday, August 18th. The stock was acquired at an average price of $1.91 per share, for a total transaction of $67,805.00. Following the completion of the purchase, the director now directly owns 164,194 shares of the company's stock, valued at approximately $313,610.54. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

董事加里·S·鲁宾在一笔日期为8月18日星期四的交易中收购了该公司35,500股股票。股票是以每股1.91美元的平均价格收购的,总交易额为67,805.00美元。收购完成后,董事现在直接持有该公司164,194股股票,价值约313,610.54美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,可以通过这个超级链接访问。

InspireMD Trading Down 1.1 %

InspirreMD股价下跌1.1%

NYSEAMERICAN NSPR traded down $0.02 during trading on Monday, reaching $1.75. 4,512 shares of the company traded hands, compared to its average volume of 24,758. The company has a market capitalization of $14.57 million, a price-to-earnings ratio of -0.59 and a beta of 1.51. InspireMD, Inc. has a 1-year low of $1.68 and a 1-year high of $5.06.

NYSEAMERICAN NSPR在周一的交易中下跌0.02美元,至1.75美元。该公司4512股易手,而其平均成交量为24,758股。该公司市值为1,457万美元,市盈率为-0.59倍,贝塔系数为1.51。InspirreMD,Inc.的一年低点为1.68美元,一年高位为5.06美元。

Get
到达
InspireMD
InspirreMD
alerts:
警报:

Analyst Upgrades and Downgrades

分析师升级和下调评级

Separately, Alliance Global Partners decreased their target price on InspireMD from $9.00 to $5.25 in a research report on Wednesday, May 11th.

另外,Alliance Global Partners在5月11日星期三的一份研究报告中将InSpireMD的目标价从9.00美元下调至5.25美元。

Institutional Inflows and Outflows

机构资金流入和流出

A hedge fund recently raised its stake in InspireMD stock. HighTower Advisors LLC grew its holdings in InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating) by 60.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,567 shares of the medical equipment provider's stock after buying an additional 10,000 shares during the quarter. HighTower Advisors LLC owned approximately 0.33% of InspireMD worth $81,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 2.09% of the company's stock.
一家对冲基金最近增持了InSpireMD股票。根据HighTower Advisors LLC在提交给美国证券交易委员会的最新Form 13F文件中显示,该公司第四季度增持了60.4%的InSpireMD,Inc.。这家机构投资者在本季度额外购买了10,000股后,持有这家医疗设备提供商的股票26,567股。在最近的报告期结束时,HighTower Advisors LLC拥有InspirreMD约0.33%的股份,价值81,000美元。机构投资者和对冲基金持有该公司2.09%的股票。

About InspireMD

关于InspirreMD

(Get Rating)

(获取评级)

InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery.

InspirreMD公司是一家医疗设备公司,专注于开发专有的MicroNet支架平台技术并将其商业化,用于治疗欧洲、拉丁美洲、中东和亚太地区的血管和冠状动脉疾病。该公司提供用于颈动脉应用的CGuard颈动脉血栓预防系统,以及用于急性冠脉综合征患者的MGuard Prime血栓保护系统,特别是急性心肌梗死、大隐静脉移植冠状动脉介入治疗以及搭桥手术。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on InspireMD (NSPR)
  • Oil Services: Who Will Lead The Rebound?
  • Analog Devices Reveals Semiconductor Demand Problems
  • Three Ways To Find Hot Stocks In A Tepid Market
  • Here are the Multiple Stages of a Bear Market
  • 3 August Earnings Reports With 'Wow' Potential
  • 免费获取StockNews.com关于InspirreMD的研究报告(NSPR)
  • 石油服务:谁将引领本轮反弹?
  • ADI公司揭露半导体需求问题
  • 在不温不火的市场中寻找热门股票的三种方法
  • 以下是熊市的多个阶段
  • 3份潜在的8月份收益报告

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.

接受《InspirreMD日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对InSpireMD和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发